The CD14 gene –159C/T polymorphism and the risk of ischemic stroke: a meta-analysis

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: To investigate the association between the CD14 –159C/T polymorphism and ischemic stroke (IS). Methods: Relevant literature was searched by retrieving EMBASE, Web of Science, Chinese National Knowledge Infrastructure, and PubMed databases. R version 3.33 software was applied to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). Results: Seven qualified studies with a total of 2058 IS patients and 2123 controls were included. There was no significant association between the CD14 –159C/T polymorphism and IS risk in the total population (TT vs CC: OR = 0.84, 95% CI = 0.58–1.20; CT vs CC: OR = 0.96, 95% CI = 0.82–1.12; dominant model: OR = 1.02, 95% CI = 0.80–1.30; recessive model: OR = 0.82, 95% CI = 0.57–1.19). Similarly, subgroup analysis according to ethnicity and Hardy–Weinberg equilibrium also found no significant interrelation. Conclusion: Our findings suggest that the CD14 –159C/T polymorphism does not contribute to the risk of IS. Well-designed studies with more subjects are required to further validate these results.

Cite

CITATION STYLE

APA

Xu, M., Wang, L., Sun, L., Li, Z., & Zhang, H. (2019). The CD14 gene –159C/T polymorphism and the risk of ischemic stroke: a meta-analysis. Journal of International Medical Research, 48(3). https://doi.org/10.1177/0300060519886241

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free